Bernard Rubin

65 papers receiving 3.2k citations

Bernard Rubin's Hit Papers

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents 1977 · 1.6k citations
1.6k0+18+36Years since publication50010001.5k

Peers

Bernard Rubin
Comparison fields: 5 of 124
  • Cardiology and Cardiovascular Medicine 1.1k
  • Cellular and Molecular Neuroscience 894
  • Nutrition and Dietetics 481
  • Molecular Biology 2.2k
  • Genetics 270
Replace Y.S. Bakhle with:
Y.S. Bakhle United Kingdom
T. Y. Shen United States
Sharron H. Francis United States
D. Palm Germany
Huy Ong Canada
Hitoshi Miyazaki Japan
Sune Bergström Sweden
F. Merlin Bumpus United States
Denis Riendeau Canada
Maurice Wibo Belgium
Bernard Rubin relative to Y.S. Bakhle United Kingdom Y.S. Bakhle's profile →
Citations per field
00.5×1.5×1.9×
Y.S. Bakhle · 1×
Citations per year

Countries citing papers authored by Bernard Rubin

Since Specialization
Citations

This map shows the geographic impact of Bernard Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Rubin more than expected).

Fields of papers citing papers by Bernard Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Rubin. The network helps show where Bernard Rubin may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Rubin Line = papers co-authored together Bernard Rubin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
Hit paper breakdown →
19771610
2
Production and Evaluation of Antibodies for the Radioimmunoassay of Gastrin
Hit paper breakdown →
1972405
3 1978193
4 1970163
5 1978160
6 1972131
7 1957114
8 1978104
9 197988
10 198063
11 198061
12 197858
13 197354
14
A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS.
196453
15 196952
16
Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
197944
17 198939
18 197837
19 197931
20 198929

About Bernard Rubin

Bernard Rubin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Rheumatology, Immunology and Pharmacology, having authored 69 papers that have together received 3.9k indexed citations. Recurring topics across this work include Protein Hydrolysis and Bioactive Peptides (13 papers), Renin-Angiotensin System Studies (12 papers), Systemic Lupus Erythematosus Research (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Hormonal Regulation and Hypertension (5 papers), Vitamin K Research Studies (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Enzyme function and inhibition (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.1k citations), Cellular and Molecular Neuroscience (894 citations), Nutrition and Dietetics (481 citations), Molecular Biology (2.2k citations) and Genetics (270 citations). Bernard Rubin has collaborated with scholars based in United States, Malaysia and Sweden. Frequent co-authors include Miguel A. Ondetti, David W. Cushman, Jens F. Rehfeld, F. Stadil, Michael J. Antonaccio, Robert J. Laffan, Zola P. Horovitz, Thomas Schaeffer, John C. Burke and M.E. Goldberg. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Experimental Biology and Medicine, Scandinavian Journal of Immunology, Rheumatology and Therapy and Journal of Cardiovascular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact